Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Janet Ecker"'
Publikováno v:
Student Success, Vol 13, Iss 3, Pp 29-36 (2022)
International students, especially those studying in English language institutes at universities in the United States, often struggle to create connections with local students and the host community. Learners of non-English languages also struggle to
Externí odkaz:
https://doaj.org/article/89151e06b53c4b09ba6a48e9a25a34b3
Autor:
Ramin Ebrahimi, John F. Flaherty, Douglas J. Ward, Awny Farajallah, Damian J McColl, Javier O Morales-Ramirez, Karen Reilly, Daniel Seekins, Benjamin Young, Edwin DeJesus, Louis Sloan, Janet Ecker, Jen-Fue Maa
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 51:163-174
Objective: To evaluate a simplification strategy for HIV-1―infected patients virologically suppressed on antiretroviral therapy (ART) by switching to a single-tablet regimen consisting of efavirenz/ emtricitabine/tenofovir disoproxil fumarate (EFV/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b91c04c23ba47dbe9a3c770d88355b0
https://doi.org/10.1097/qai.0b013e3181a572cf
https://doi.org/10.1097/qai.0b013e3181a572cf
Autor:
Awny Farajallah, Stephen Esker, Kristy Grimm, John F. Flaherty, Sally Hodder, Janet Ecker, Edwin DeJesus, Karam Mounzer, Ramin Ebrahimi
Publikováno v:
AIDS patient care and STDs. 24(2)
A randomized, open-label, multicenter study was conducted to evaluate the therapeutic switch to a single-tablet formulation of efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) among virologically suppressed, HIV-1-infected subjects. Eligible subjec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a40f91ee88d51593ffc002a6f20b80
https://pubmed.ncbi.nlm.nih.gov/20156091
https://pubmed.ncbi.nlm.nih.gov/20156091
Autor:
Roberto Corales, John P. Flaherty, Shetal Sharma, Homayoun Khanlou, Cheryl McDonald, Edwin DeJesus, Ramin Ebrahimi, Peter Ruane, Fernando Garcia, Janet Ecker, David Shamblaw, Jayashree Ravishankar
Publikováno v:
HIV clinical trials. 9(2)
Evaluate the impact of switching from twice-daily zidovudine/lamivudine (AZT/3TC) to once-daily tenofovir DF plus emtricitabine (TDF/FTC) with efavirenz (EFV).Prospective, multicenter, single-arm 24-week trial.Patients on EFV + AZT/3TC foror =8 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e457d9348abec4024c222558eb3573
https://pubmed.ncbi.nlm.nih.gov/18474495
https://pubmed.ncbi.nlm.nih.gov/18474495
Autor:
Edwin DeJesus, Peter Ruane, Cheryl McDonald, Fernando Garcia, Shetal Sharma, Roberto Corales, Jayashree Ravishankar, Homayoun Khanlou, David Shamblaw, Janet Ecker, Ramin Ebrahimi, John Flaherty
Publikováno v:
HIV Clinical Trials; Mar2008, Vol. 9 Issue 2, p103-114, 12p